E. H. Warren

T-cell therapy of leukemia.

S. Riddell, M. Murata, S. Bryant, 2002, Cancer control : journal of the Moffitt Cancer Center.

Minor histocompatibility antigens-targets of graft versus leukemia responses

E. Warren, S. Riddell, M. Murata, 2002, International journal of hematology.

Non-myeloablative transplants for malignant disease.

R. Storb, E. Warren, S. Riddell, 2001, Hematology. American Society of Hematology. Education Program.

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

H. Deeg, J. Radich, R. Storb, 2003 .

The toxicity of certain chlorine derivatives of benzene, with special reference to o‐dichlorobenzene

G. Cameron, E. H. Warren, J. L. Buchan, 1937 .

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities.

H. Deeg, K. Loeb, M. Sorror, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

H. Deeg, J. Radich, S. Heimfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.